Microtubule/Tubulin inhibitor, Cabazitaxel, Purity ≥98%

Cat. No.: X24-08-YM222

Microtubule/Tubulin inhibitor, Cabazitaxel, Purity ≥98%

Synonym: 183133-96-2; TXD-258; XRP 6258; Jevtana; Taxoid XRP6258; Xrp6258; [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-Acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

  • MDL: MFCD18827611
  • CAS Number: 183133-96-2
  • Compound CID: 9854073
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Cabazitaxel, soluble in DMSO and insoluble in water and ethanol, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
835.93
Molecular Formula
C45H57NO14
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 91 mg/mL (108.85 mM); Water: insoluble; Ethanol: insoluble
Applications
Cabazitaxel is a cytoskeletal signaling inhibitor that plays a key role in inhibiting microtubule depolymerization, which disrupts mitosis and induces cell death in cancer cells.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0